How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

10,764 results for

Management of Severe Head Injury

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Management of screwdriver-induced penetrating brain injury: a case report. Full Text available with Trip Pro

Management of screwdriver-induced penetrating brain injury: a case report. Penetrating brain injury (PBI) can be caused by several objects ranging from knives to chopsticks. However, an assault with long and electric screwdriver is a peculiar accident and is relatively rare. Because of its rarity, the treatments of such injury are complex and nonstandardized.We presented a case of a 54-year-old female who was stabbed with a screwdriver in her head and accompanied by loss of consciousness for 1 (...)  h. Computer tomography (CT) demonstrated that the screwdriver passed through the right zygomatic bone to posterior cranial fossa. Early foreign body removal and hematoma evacuation were performed and the patient had a good postoperative recovery.In this study, we discussed the clinical presentation and successful management of such a unique injury caused by a screwdriver. Our goal is to demonstrate certain general management principles which can improve patient outcomes.

2017 BMC Surgery

82. Guidelines on Supraventricular Tachycardia (for the management of patients with) Full Text available with Trip Pro

and electrophysiological procedures. The ESC published management Guidelines for supraventricular tachycardias (SVTs) in 2003 ; corresponding US guidelines have also been published, the most recent being in 2015. There is a need to provide expert recommendations for professionals participating in the care of patients presenting with SVT. In addition, several associated conditions where SVTs may coexist need to be explained in more detail. To address this topic, a Task Force was convened by the ESC, with the remit (...) by agreement of the expert panel after thorough deliberation. The document was peer-reviewed by official external reviewers. The strengths of the recommendations and levels of evidence of particular management options were weighed and graded according to predefined scales, as outlined above in Tables and , respectively. Overall, these Guidelines include evidence and expert opinions from several countries. The pharmacological and non-pharmacological antiarrhythmic approaches discussed may therefore include

2019 European Society of Cardiology

83. Diagnosis and Management of Acute Pulmonary Embolism Full Text available with Trip Pro

Assessment of pulmonary embolism severity and the risk of early death 18 5.1 Clinical parameters of pulmonary embolism severity 18 5.2 Imaging of right ventricular size and function 18 5.2.1 Echocardiography 18 5.2.2 Computed tomographic pulmonary angiography 19 5.3 Laboratory biomarkers 19 5.3.1 Markers of myocardial injury 19 5.3.2 Markers of right ventricular dysfunction 19 5.3.3 Other laboratory biomarkers 19 5.4 Combined parameters and scores for assessment of pulmonary embolism severity 20 5.5 (...) for high-risk PE (Section 6.1). A dedicated management algorithm is proposed for high-risk PE ( Supplementary Figure ). NOACs are recommended as the first choice for anticoagulation treatment in a patient eligible for NOACs; VKAs are an alternative to NOACs. The risk-adjusted management algorithm ( Figure ) was revised to take into consideration clinical PE severity, aggravating conditions/comorbidity, and the presence of RV dysfunction. Chronic treatment after the first 3 months Risk factors for VTE

2019 European Society of Cardiology

84. Management of Poisoning

It is estimated that 350,000 people died worldwide from unintentional poisoning in 2002. 1 In Singapore, injuries (including poisoning) ranked as the ? fth leading cause of death and the leading cause of hospitalisation from 2007 to 2009. The pattern of poisoning has changed as the public is now exposed to other new drugs and chemicals. New antidotes and therapies have also been developed for the management of such poisoning, and are now available to health professionals. The Ministry of Health released its (...) and should be avoided unless necessary (pg 101). Grade D, Level 3 D If intubation and mechanical ventilation is necessary for severe obtundation, hypotension, hypoventilation or severe metabolic acidosis, ensure appropriately high minute ventilation and maintain alkalemia (via serial blood gas analysis) with serum pH 7.50-7.55 (pg 101). Grade D, Level 4 D Consider haemodialysis for patients who require intubation (pg 102). Grade D, Level 412 D Pulmonary oedema and acute lung injury may occur and should

2020 Ministry of Health, Singapore

85. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children Full Text available with Trip Pro

is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website ( ). Drs. Weiss and Peters served as arbiters for conflict interest management and adjudication throughout the guidelines process following standard operating procedures set forth by Society of Critical Care Medicine (SCCM) and endorsed by European Society of Intensive Care Medicine. Dr. Weiss participates in Pediatric Acute Lung Injury (...) the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. Methods: The panel consisted of six subgroups: recognition and management of infection , hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence

2020 Society of Critical Care Medicine

86. American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee

making treatment decisions for the management of OA. Clinicians and patients should engage in shared decision- making that accounts for patients’ values, preferences, and comor- bidities. These recommendations should not be used to limit or deny access to therapies. Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are in- tended to provide guidance for patterns of practice and not to dictate the care of a particular patient. The ACR considers (...) conditions, such as hypertension, cardi- ovascular disease, heart failure, gastrointestinal bleeding risk, chronic kidney disease, or other comorbidities, that might have an impact on their risk of side effects from certain pharmacologic agents, as well as injuries, disease severity, surgical history, and access to and availability of services (transportation, distance, ability to take time off work, cost, insurance coverage) that might have an impact on the choice of physical, psychological, and mind

2020 American College of Rheumatology

87. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

of a lack of sensitivity and specificity compared with viral genome polymerase chain reaction performed on endomyocardial tissue obtained by biopsy. The emergency department and outpatient diagnosis of FM has several diagnostic pearls and potential pitfalls (partially listed in ) that should be kept in mind by frontline providers in the outpatient setting. Table 1. Potential Pearls and Pitfalls in the Evaluation and Early Management of FM Diagnosis Consider myocarditis in young patients with apparent (...) and Management Issues During Hospital Admission for FM: Roles for Multimodality Imaging and EMB Echocardiography Because of rapid and portable acquisition, echocardiography remains the first test in most cases of FM, with the ability to rapidly process a wide differential diagnosis (including pericardial disease) and to assess cardiac and valvular function and morphology. Early use of echocardiography is essential to establish a diagnosis and the severity of cardiovascular compromise. Apart from cardiac

2020 American Heart Association

88. The management of obstructive azoospermia: a committee opinion

The management of obstructive azoospermia: a committee opinion The management of obstructive azoospermia: a committee opinion PracticeCommitteeoftheAmericanSocietyforReproductiveMedicineincollaborationwiththeSocietyfor Male Reproduction and Urology American Society for Reproductive Medicine, Birmingham, Alabama Infertilityduetoobstructiveazoospermiamaybetreatedeffectivelybysurgicalreconstructionorbyretrievalofspermfromtheepidid- ymisortestis (...) to a complete absence of sperm in the ejaculate, and accounts for approximately 40% of all cases of azoospermia (1). Obstruction may be congenitaloracquiredandmayinclude oneormoresegmentsofthemalerepro- ductive tract: epididymis, vas deferens, and ejaculatory ducts. Congenital causes of obstructive azoospermia include congenital bilateral absence of thevasdeferens(CBAVD)andidiopathic epididymal obstruction. Acquired causes of obstructive azoospermia include vasectomy, infection, trauma, or iatrogenic injury

2020 Society for Assisted Reproductive Technology

89. Management of Cancer Medication-Related Infusion Reactions

• For high-risk patients (e.g. patients who experienced severe anaphylaxis during the initial infusion, as well as patients with severe respiratory or cardiac disease and patients who are pregnant), a four-bag 16 step protocol can be used. 112,118,119,127 Management of Cancer Medication-Related Infusion Reactions 19 RECOMMENDATIONS FOR INFUSION REACTION PROPHYLAXIS [Return to Table 1.1] Risk Factors Given the potential for life-threatening injury when an IR occurs, it is important to consider all (...) whatsoever regarding the report content or use or application and disclaims any responsibility for its application or use in any way Management of Cancer Medication-Related Infusion Reactions 2 ACKNOWLEDGEMENTS Working Group Members Dr. Leta Forbes, Medical Oncologist, Provincial Head, Systemic Treatment Program, Cancer Care Ontario, Co-chair Andrea Crespo, Sr. Pharmacist, Systemic Treatment Program, Cancer Care Ontario, Co-chair Daniela Gallo-Hershberg, Pharmacist, Group Manager, Systemic Treatment

2019 Cancer Care Ontario

90. Guidelines on Management of Dyspnea (Breathlessness) in Patients with Cancer

on Management of Dyspnea Page 5 the literature search was not designed to locate these guidelines, additional guidelines on these topics may exist. The list for COPD is more extensive, with several of the guidelines identified from references in other guidelines. Guidelines Focused on Dyspnea or Symptom Management The guideline by the Japanese Society for Palliative Medicine covers palliative interventions for respiratory symptoms in cancer and is probably the most comprehensive for the therapies it covers (...) series by the Oncology Nursing Society [3] includes literature until January 2017. The recommendations include several topics that were not part of the literature search strategy. It lists agents by strength of evidence and recommendation, then citations to supporting evidence, but provides no further analysis or guidance as to when or how to use specific interventions. The user would need to read items on the list of citations for each treatment, and therefore its use appears mainly as a list

2019 Cancer Care Ontario

91. Programmatic management of latent tuberculosis infection in the European Union

Programmatic management of latent tuberculosis infection in the European Union SCIENTIFIC ADVICE Programmatic management of latent tuberculosis infection in the European Union www.ecdc.europa.euECDC SCIENTIFIC ADVICE Programmatic management of latent tuberculosis infection in the European Union ii This guidance was commissioned by ECDC and coordinated by Senia Rosales Klintz, Netta Beer and Marieke J. van der Werf with the support of Helena de Carvalho Gomes (ECDC). The inventory of expert (...) in the European Union 2 1.2 Scope and objectives of the guidance 2 1.3 Target audience 2 2. Background 3 2.1 Tuberculosis and latent tuberculosis infection 3 2.2 TB/LTBI as a public health priority for EU/EEA 3 3. Guidance development 4 3.1 Inventory of expert opinions 4 3.2 Evidence collection, appraisal and synthesis 5 3.3 Expert consultation 7 4. Conclusions 8 4.1 Target risk groups 8 4.2 Diagnosis of LTBI 16 4.3 Treatment of LTBI 18 4.4 Programmatic issues of LTBI management 21 4.5 ECDC assessment 27 5

2019 European Centre for Disease Prevention and Control - Public Health Guidance

92. Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer

Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer Evidence-Based Series 2-4 Version 3 A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer Members of the Gastrointestinal Cancer Disease Site Group Evidence-based Series (EBS) 2-4 Version 3 was reviewed in 2019 and ENDORSED by the Gastrointestinal (...) Section 4: Document Review Summary and Review Tool March 13, 2019 For information about this document, the PEBC and/or the most current version of all reports, please visit the CCO web site at http://www.cancercare.on.ca/ or contact the PEBC office at: Phone: 905-527-4322 ext. 42822 Fax: 905-526-6775 Email: ccopgi@mcmaster.ca PEBC Report Citation (Vancouver Style): Wong R, Berry S, Spithoff K, Simunovic M, Chan K, Agboola O, et al. Preoperative or postoperative therapy for the management of patients

2019 Cancer Care Ontario

93. Management of stable angina

myocardial perfusion is due to arterial narrowing resulting from underlying atherosclerotic CAD. Stable angina is usually assessed in the outpatient setting. It is important when taking a clinical history to identify, and manage appropriately, those patients whose symptoms may be due to the more severe changes of plaque erosion and rupture occurring as part of the spectrum of acute coronary syndrome (see SIGN guideline number 148 on acute coronary syndromes). 10 1.2.3 TARGET USERS OF THE GUIDELINE (...) is a symptom that suggests an individual has underlying obstructive CAD. Investigation to confirm the severity and extent of underlying CAD will allow management strategies to be developed and optimise cardiovascular risk reduction. 14 A significant proportion of patients with chest pain will not have angina and initial assessment should try to identify alternative diagnoses for these patients at an early stage. Patients with acute cardiac chest pain (suspected acute coronary syndrome) are outside

2018 SIGN

94. Diagnosis and management of epilepsy in adults

after a seizure, and by recordings during sleep or following sleep deprivation. 16, 37, 38 Incidental epileptiform abnormalities are found in 0.5% of healthy young adults, but are more likely in people with learning disability and psychiatric disorders, patients with previous neurological insult (for example head injury, meningitis, stroke, cerebral palsy), and patients who have undergone neurosurgery. 39-41 Diagnosis and management of epilepsy in adults 3 • Diagnosis 2 +10 | In a patient in whom (...) for children the risks are higher after less than two years of seizure freedom than for more than two years. 153 Diagnosis and management of epilepsy in adults 4 • Treatment 2 + 2 - 2 + 1 + 1 ++20 | The effect of different rates of AED withdrawal on the risk of seizure recurrence has not been adequately studied. Important factors influencing a decision about AED withdrawal in adults include driving, employment, fear of further seizures, risks of injury or death with further seizures and concerns about

2018 SIGN

95. Intracranial Pressure Monitoring in Sever Traumatic Brain Injury Single Center Experience

Intracranial Pressure Monitoring in Sever Traumatic Brain Injury Single Center Experience Intracranial Pressure Monitoring in Sever Traumatic Brain Injury Single Center Experience - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Intracranial Pressure Monitoring in Sever Traumatic Brain Injury Single Center Experience The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03721003 Recruitment Status : Not yet recruiting First

2018 Clinical Trials

96. Intensive care treatments associated with favorable discharge outcomes in Argentine children with severe traumatic brain injury: For the South American Guideline Adherence Group. Full Text available with Trip Pro

Intensive care treatments associated with favorable discharge outcomes in Argentine children with severe traumatic brain injury: For the South American Guideline Adherence Group. Little is known about the critical care management of children with traumatic brain injury (TBI) in low middle income countries. We aimed to identify indicators of intensive care unit (ICU) treatments associated with favorable outcomes in Argentine children with severe TBI.We conducted a secondary analysis of data from (...) patients previously enrolled in a prospective seven center study of children with severe TBI who were admitted to an ICU in one of the seven study centers. Severe TBI was defined by head AIS ≥ 3, head CT with traumatic lesion, and admission GCS < 9. Seven indicators of best practice TBI care were examined. The primary outcome was discharge Pediatric Cerebral Performance Category Scale [PCPC] and Pediatric Overall Performance category Scale [POPC]. We also examined variation in ICU care and in-patient

2017 PLoS ONE

97. PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)

PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) Brain Injury Drug: Dalteparin Drug: Saline Phase 3 Detailed Description: Patients with severe brain injury are at risk for developing blood clots in their legs, which can travel to the lungs. This potentially serious complication is known as venous thromboembolism (VTE). Anticoagulants are commonly used to prevent VTE in hospital patients. However, in patients with major head injury, anticoagulant prevention is commonly delayed for the fear that it can potentially lead to further bleeding

2018 Clinical Trials

98. Systematic Review - Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders

Synthesis Program ii ACKNOWLEDGMENTS This topic was developed in response to a nomination by Stuart Hoffman, PhD, Scientific Program Manager for Brain Injury and Senior Scientific Advisor for Brain Injury; Ralph DePalma, MD, FACS, Special Operations Officer; and David X. Cifu, MD, National Director of Physical Medicine and Rehabilitation Program Office and Chair, VHA TBI Advisory Committee, for use by the VHA TBI Advisory Committee to inform clinical practice guideline development and by the Office (...) Panel (TEP) participants; assure VA relevance; help develop and approve final project scope and timeframe for completion; provide feedback on draft report; and provide consultation on strategies for dissemination of the report to field and relevant groups. Stuart Hoffman, PhD Scientific Program Manager for Brain Injury and Senior Scientific Advisor for Brain Injury Office of Research and Development Ralph DePalma, MD, FACS Special Operations Officer David X. Cifu, MD National Director of Physical

2019 Veterans Affairs Evidence-based Synthesis Program Reports

99. Traumatic Brain Injury and Dementia

on the Management of Concussion-mild Traumatic Brain (mTBI) (2016) 14 and the Brain Trauma Foundation’s 4 th Edition of Guidelines for Management of Severe Traumatic Brain Injury (2016). 15 Furthermore, increased public awareness and concern about reports of Chronic Traumatic Encephalopathy (CTE) in active-duty service members has heightened the urgency to better understand the potential chronic neurodegenerative risks of TBI. 16,17 CTE is a neurodegenerative condition first recognized in contact sports (...) Consortium. Goals and Mission. https://cenc.rti.org/Goals-and-Mission. Accessed December 12, 2018. 14. The Management of Concussion-mild Traumatic Brain Injury Working Group. VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF CONCUSSION-MILD TRAUMATIC BRAIN INJURY. Department of Veterans Affairs, Department of Defense; 2016. Evidence Brief: TBI and Dementia Evidence Synthesis Program 22 15. Carney MN, Totten SA, O'reilly WJC, et al. Guidelines for the management of severe traumatic brain injury

2019 Veterans Affairs Evidence-based Synthesis Program Reports

100. A review of pressure injury rates in Australian hospitals

) published a safety and quality improvement guide for Standard 8 – the prevention and management of pressure injuries [1] . As a result, robust audit and data collection systems should be developed to evaluate the effectiveness of current strategies and identify areas where improvements can be made. Consequently, health service organisations should ensure that mechanisms are in place to collect data on incidence, prevalence and severity of pressure injuries [2] . To ensure the highest quality of care (...) a safety and quality improvement guide for Standard 8 – the prevention and management of pressure injuries [1] . As a result, robust audit and data collection systems should be developed to evaluate the effectiveness of current strategies and identify areas where improvements can be made. Consequently, health service organisations should ensure that mechanisms are in place to collect data on incidence, prevalence and severity of pressure injuries [2] . To ensure the highest quality of care for our

2019 Monash Health Evidence Reviews

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>